Notably, our results suggest that cg26343298 methylation is protective against type 2 diabetes and diabetic nephropathy, and the cg26343298 methylation site negatively regulates TP53INP1 expression, indicating a correlation between DNA methylation, TP53INP1 expression, and diabetes risk. Here, TP53INP1 is linked to diabetic kidney disease.